A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation

dc.citation.epage335pt_BR
dc.citation.issue4pt_BR
dc.citation.spage330pt_BR
dc.citation.volume9pt_BR
dc.creatorAtalla, Angelo
dc.creatorMaiolino, Angelo
dc.creatorGuimarães, Maria Angélica
dc.creatorGuimarães, Antonio Carlos
dc.creatorNucci, Marcio
dc.date.accessioned2019-02-22T12:04:00Z
dc.date.available2019-02-18
dc.date.available2019-02-22T12:04:00Z
dc.date.issued2005-08
dc.description.abstractThe reactivation of Herpes Simplex virus (HSV) occurs in 70% to 80% of patients submitted to autologous stem cell transplantation (ASCT); it increases the severity of chemotherapy-induced mucositis. Therefore, the use of acyclovir in ASCT patients is considered standard practice. However, the minimum dose needed to prevent reactivation is a matter of debate. We compared two doses of acyclovir in a non-randomized fashion in 59 patients submitted to ASCT: 32 patients received a dose of 125 mg/m2 IV every six hours and the subsequent 27 patients received a dose of 60 mg/m2 IV every six hours. Viral excretion was evaluated through weekly viral culture of oral swabs. Grade 4 mucositis was more frequent in Group 1 (p= 0.03). The reactivation rates in Groups 1 and 2 were 9% and 4%, respectively (p= 0.62, 95% confidence interval -7 - 18). Prophylaxis with reduced doses of intravenous acyclovir seems to be as effective as a higher dose in inhibiting HSV reactivation, with a significant reduction in cost. Prospective randomized studies are needed to confirm our conclusions.pt_BR
dc.description.resumo-pt_BR
dc.identifier.doihttp://dx.doi.org/10.1590/S1413-86702005000400010pt_BR
dc.identifier.urihttps://repositorio.ufjf.br/handle/ufjf/9102
dc.languageengpt_BR
dc.publisher-pt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.initials-pt_BR
dc.relation.ispartofBrazilian Journal of Infectious Diseasespt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectAcyclovirpt_BR
dc.subjectProphylaxispt_BR
dc.subjectStem cell transplantationpt_BR
dc.subject.cnpq-pt_BR
dc.titleA non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantationpt_BR
dc.typeArtigo de Periódicopt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
A non-randomized comparative study using different doses of acyclovir to prevent herpes.pdf
Size:
34.38 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.15 KB
Format:
Item-specific license agreed upon to submission
Description: